Insider Purchases: Inside the Buy
Tag: ValueInvesting
Can a Tiny Insider Buy at Conagra Signal the Next Big Bull?
Conagra might not be hot sauce, but it’s finally warming up. A small insider buy, strong institutional backing, and a fat dividend yield could turn this frozen-aisle veteran into a comeback story. Just keep an eye on inflation and margins — both can melt fast.
W&T Offshore (WTI): CEO Buys Shares, But the Tide May Still Be Out
W&T Offshore (WTI): Deep Value or Deep Trouble?
Houston’s oil-and-gas veteran has been drilling for 40 years — and shareholders are still waiting to strike gold. With the CEO buying more shares while shorts circle overhead, the battle for the Gulf of America’s future is heating up. Production’s up, cash flow’s steady, and the dividend still drips — but with a stock 97% below its all-time high, is this a comeback story or a cautionary tale?
Financials Paint a Dire Story… But Tronox’s CEO and Insiders See Light in the TiO₂ Pigment
Tronox isn’t just about titanium dioxide anymore—it’s about insider confidence, global reach, and whether this chemical giant’s bright white future is worth your green 💵. From insider purchases to institutional moves, here’s why investors might want to watch TROX closely.
International Flavors & Fragrances Inc. (IFF): Insiders Buy Big, CEO Doubles Down, and the Scent of Value Is in the Air
Insiders at International Flavors & Fragrances (IFF) are loading up on shares—CEO included. With a $500M buyback, big-name institutional holders, and portfolio reshaping, the stock could be brewing a comeback. But is it perfume… or still a whiff of trouble?
COO Goes Shopping: Is Molina Healthcare (MOH) a Healthy Buy or Just a Check-Up?
When the COO of Molina Healthcare spends $1.56M on stock, investors notice. With Wall Street titans on board and shares at major support, is this a healthy buy — or a risky patient?
Simmons Bank: Insider Buys, 116 Years of Dividends, and a Footlong Public Offering
Simmons Bank has paid dividends for over a century—and insiders just went on a buying spree. 📉 Stock’s dipped, 🔍 valuation isn’t screaming cheap, but with improving net income and institutional support, SFNC might be worth a second look. If not exciting, at least it’s… dependable?
Can Elevance Reach Higher Elevations? The CEO Thinks So
📉 After falling nearly 50% from its highs, Elevance Health just got a $2.4M vote of confidence from its CEO. Is this the cure—or just another symptom? 🏥 Dive into the numbers, the risks, and the potential rewards. And yes, there will be icons. 📊💊📈
Helen of Troy (HELE) — Insider Buys, CFOs Turned CEOs, and a Falling Knife You Might Want to Catch (Carefully)
The CEO and CFO of Helen of Troy just bought shares as the stock plunges 90%. Are we looking at a tragic tale, or a comeback for the ages? We dig into the numbers, leadership shuffle, and Wall Street signals—with humor and historical flair.
PVH: Fashion. Fundamentals. CEO Buying. Doesn't the $500M Share Buyback Scream Deep Value?
CEO Stefan Larsson just bought $1M worth of PVH stock—and he’s not alone. With iconic brands like Calvin Klein and Tommy Hilfiger, institutional support over 100%, and a massive share buyback underway, PVH may be a classic turnaround play. But is it fashionably early… or just fashionably risky?
Insiders Are Buying ConocoPhillips. Should You?
Insiders are drilling into COP shares—and they're not alone. With a $10B return plan, strong reserves, and a smart buyout of Marathon Oil, ConocoPhillips might just be the contrarian pick of the year. Here's the fun, smart breakdown.